However, relying on pharmaceutical drugs for weight loss, enhanced performance, or treatment of common ailments—without professional guidance—can lead to short-sighted and often harmful consequences.

In India, around 101 million people suffer from diabetes. More than half of these patients do not have their blood sugar ...

The Bryan County Sheriff's Office says that one person has died following an incident at the Hyundai Megasite. Officials ...

Join a real-time written chat with WSJ’s Bradley Olson on Monday, March 24, from 3 p.m. to 4 p.m. ET. WSJ subscribers can ...

I’m one of the millions of people trying to keep the weight off without taking expensive drugs like Mounjaro or Ozempic for ...

A coalition of over 20 leading health organizations is calling on the U.S. Food & Drug Administration (FDA) to enforce ...

Counterfeit medications are a growing menace, with alarming revelations surfacing about dangerous fake weight-loss drugs circulating among consumers. U.S. and UK health authorities have issued urgent ...

Copycat versions of Eli Lilly’s diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They’re still available on some websites.

In 2023, the United States marked a major milestone in the battle against a longstanding public health crisis: adult obesity rates dropped for the first time in a decade. Researchers pointed to GLP-1s ...

Destination XL Group struggles with negative trends and a shrinking market. Find out why DXLG stock is a Hold, with no reversal in sight for its sales issues.

Drug compounders are moving to block the FDA’s decision that Novo Nordisk A/S’s weight loss drug is no longer in shortage, ...

The makers of weight-loss drugs Wegovy and Zepbound are lowering prices significantly, effective immediately, to make them more affordable.